Prashant C. Shah, MD, Joins Fox Chase's Department of Surgical Oncology

PHILADELPHIA (October 15, 2010) – Prashant C. Shah, MD, has joined Fox Chase Cancer Center’s Department of Surgical Oncology as an attending surgeon in the Division of Thoracic Oncology. He specializes in complex thoracic cancer cases, minimally invasive foregut/esophageal surgery, VATS lung and mediastinal surgery, and the surgical management of mesothelioma. He also has specialized training in treating patients with many types of benign thoracic surgical problems, such as GERD, hyperhidrosis, Barrett’s esophagus, and achalasia.

“With a strong training background in VATS and minimally invasive techniques, I hope to work with the Fox Chase team to discover new ways of broadening the applications of minimally invasive thoracic surgery,” Shah says.

Shah comes to Fox Chase from Brigham and Women’s Hospital in Boston, where he completed Harvard fellowships in advanced minimally invasive thoracic surgery and advanced thoracic oncology. During his time in Boston, Shah was featured on “Boston Med,” an ABC News series about hospitals in Boston, Mass.

“I chose Fox Chase for a number of reasons,” Shah explains. “As a highly-ranked comprehensive cancer center, Fox Chase not only stays on the cutting edge of cancer treatment, but also pioneers the newest, most advanced techniques. The clinical team’s multidisciplinary approach gives patients access to a variety of experts who work together to offer the most effective treatment strategies.”

After earning his MD at St. George’s University School of Medicine in Grenada, Shah completed his residency in general surgery at Maimonides Medical Center in Brooklyn. He also completed a cardiothoracic surgery fellowship at SUNY Downstate Health Science Center and Maimonides Medical Center after finishing his residency. He is a member of the New York Society of Thoracic Surgeons.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text